nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Trismus—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0564	CcSEcCtD
Ixabepilone—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0368	CcSEcCtD
Ixabepilone—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0115	0.034	CcSEcCtD
Ixabepilone—Embolism—Riluzole—amyotrophic lateral sclerosis	0.00995	0.0293	CcSEcCtD
Ixabepilone—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.00902	0.0266	CcSEcCtD
Ixabepilone—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00902	0.0266	CcSEcCtD
Ixabepilone—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0261	CcSEcCtD
Ixabepilone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00855	0.0252	CcSEcCtD
Ixabepilone—TUBB4A—hindbrain—amyotrophic lateral sclerosis	0.00796	0.0568	CbGeAlD
Ixabepilone—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00795	0.0234	CcSEcCtD
Ixabepilone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00795	0.0234	CcSEcCtD
Ixabepilone—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00707	0.0208	CcSEcCtD
Ixabepilone—TUBB2A—Post-chaperonin tubulin folding pathway—TUBA4A—amyotrophic lateral sclerosis	0.00663	0.0127	CbGpPWpGaD
Ixabepilone—TUBB6—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00654	0.0126	CbGpPWpGaD
Ixabepilone—TUBB2B—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00654	0.0126	CbGpPWpGaD
Ixabepilone—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0065	0.0192	CcSEcCtD
Ixabepilone—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0065	0.0192	CcSEcCtD
Ixabepilone—TUBB1—Post-chaperonin tubulin folding pathway—TUBA4A—amyotrophic lateral sclerosis	0.00648	0.0125	CbGpPWpGaD
Ixabepilone—TUBB3—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00632	0.0121	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—RNF19A—amyotrophic lateral sclerosis	0.00622	0.0119	CbGpPWpGaD
Ixabepilone—TUBB2A—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00612	0.0118	CbGpPWpGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00599	0.0115	CbGpPWpGaD
Ixabepilone—TUBB1—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00599	0.0115	CbGpPWpGaD
Ixabepilone—TUBB4A—Post-chaperonin tubulin folding pathway—TUBA4A—amyotrophic lateral sclerosis	0.00582	0.0112	CbGpPWpGaD
Ixabepilone—TUBB6—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00578	0.0111	CbGpPWpGaD
Ixabepilone—TUBB2B—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00578	0.0111	CbGpPWpGaD
Ixabepilone—TUBB8—nervous system—amyotrophic lateral sclerosis	0.00575	0.0411	CbGeAlD
Ixabepilone—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—VAPA—amyotrophic lateral sclerosis	0.00568	0.0109	CbGpPWpGaD
Ixabepilone—TUBB3—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00559	0.0107	CbGpPWpGaD
Ixabepilone—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00554	0.0163	CcSEcCtD
Ixabepilone—TUBB8—central nervous system—amyotrophic lateral sclerosis	0.00554	0.0396	CbGeAlD
Ixabepilone—TUBB2A—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00541	0.0104	CbGpPWpGaD
Ixabepilone—TUBB4A—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00537	0.0103	CbGpPWpGaD
Ixabepilone—TUBB2B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00535	0.0103	CbGpPWpGaD
Ixabepilone—TUBB6—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00535	0.0103	CbGpPWpGaD
Ixabepilone—TUBB4B—Post-chaperonin tubulin folding pathway—TUBA4A—amyotrophic lateral sclerosis	0.00532	0.0102	CbGpPWpGaD
Ixabepilone—TUBB1—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00529	0.0102	CbGpPWpGaD
Ixabepilone—TUBB2B—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00527	0.0101	CbGpPWpGaD
Ixabepilone—TUBB6—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00527	0.0101	CbGpPWpGaD
Ixabepilone—TUBB6—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.0052	0.00998	CbGpPWpGaD
Ixabepilone—TUBB2B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.0052	0.00998	CbGpPWpGaD
Ixabepilone—TUBB3—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00517	0.00993	CbGpPWpGaD
Ixabepilone—TUBB3—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00509	0.00978	CbGpPWpGaD
Ixabepilone—TUBB3—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.00502	0.00964	CbGpPWpGaD
Ixabepilone—TUBB2A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00501	0.00961	CbGpPWpGaD
Ixabepilone—TUBB4A—embryo—amyotrophic lateral sclerosis	0.00498	0.0356	CbGeAlD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00494	0.00949	CbGpPWpGaD
Ixabepilone—TUBB2A—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00493	0.00947	CbGpPWpGaD
Ixabepilone—TUBB4B—Formation of tubulin folding intermediates by CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00492	0.00944	CbGpPWpGaD
Ixabepilone—TUBB1—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.0049	0.0094	CbGpPWpGaD
Ixabepilone—TUBB2A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.00486	0.00934	CbGpPWpGaD
Ixabepilone—TUBB1—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00482	0.00926	CbGpPWpGaD
Ixabepilone—TUBB1—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.00475	0.00913	CbGpPWpGaD
Ixabepilone—TUBB4A—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00475	0.00912	CbGpPWpGaD
Ixabepilone—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00465	0.0137	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0137	CcSEcCtD
Ixabepilone—TUBB4A—brainstem—amyotrophic lateral sclerosis	0.00456	0.0326	CbGeAlD
Ixabepilone—TUBB8—brain—amyotrophic lateral sclerosis	0.0044	0.0314	CbGeAlD
Ixabepilone—TUBB4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.0044	0.00844	CbGpPWpGaD
Ixabepilone—TUBB4B—Chaperonin-mediated protein folding—XRN2—amyotrophic lateral sclerosis	0.00434	0.00834	CbGpPWpGaD
Ixabepilone—TUBB4A—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00433	0.00832	CbGpPWpGaD
Ixabepilone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0127	CcSEcCtD
Ixabepilone—TUBB4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.00427	0.0082	CbGpPWpGaD
Ixabepilone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00422	0.0124	CcSEcCtD
Ixabepilone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0121	CcSEcCtD
Ixabepilone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0121	CcSEcCtD
Ixabepilone—TUBB4B—Prefoldin mediated transfer of substrate to CCT/TriC—TUBA4A—amyotrophic lateral sclerosis	0.00402	0.00772	CbGpPWpGaD
Ixabepilone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0118	CcSEcCtD
Ixabepilone—TUBB4B—Protein folding—XRN2—amyotrophic lateral sclerosis	0.00396	0.00761	CbGpPWpGaD
Ixabepilone—TUBB3—nervous system—amyotrophic lateral sclerosis	0.00393	0.0281	CbGeAlD
Ixabepilone—TUBB4B—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA4A—amyotrophic lateral sclerosis	0.0039	0.0075	CbGpPWpGaD
Ixabepilone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0115	CcSEcCtD
Ixabepilone—TUBB4B—embryo—amyotrophic lateral sclerosis	0.00388	0.0277	CbGeAlD
Ixabepilone—TUBB1—nervous system—amyotrophic lateral sclerosis	0.00384	0.0274	CbGeAlD
Ixabepilone—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00381	0.0112	CcSEcCtD
Ixabepilone—TUBB3—central nervous system—amyotrophic lateral sclerosis	0.00378	0.027	CbGeAlD
Ixabepilone—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00375	0.011	CcSEcCtD
Ixabepilone—TUBB1—central nervous system—amyotrophic lateral sclerosis	0.0037	0.0264	CbGeAlD
Ixabepilone—TUBB3—cerebellum—amyotrophic lateral sclerosis	0.00369	0.0264	CbGeAlD
Ixabepilone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00363	0.0107	CcSEcCtD
Ixabepilone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0106	CcSEcCtD
Ixabepilone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00357	0.0105	CcSEcCtD
Ixabepilone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00357	0.0105	CcSEcCtD
Ixabepilone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0104	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0103	CcSEcCtD
Ixabepilone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0103	CcSEcCtD
Ixabepilone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0103	CcSEcCtD
Ixabepilone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0103	CcSEcCtD
Ixabepilone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0102	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00996	CcSEcCtD
Ixabepilone—TUBB6—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00332	0.00638	CbGpPWpGaD
Ixabepilone—TUBB2B—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00332	0.00638	CbGpPWpGaD
Ixabepilone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00322	0.0095	CcSEcCtD
Ixabepilone—TUBB3—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00321	0.00616	CbGpPWpGaD
Ixabepilone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00945	CcSEcCtD
Ixabepilone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0094	CcSEcCtD
Ixabepilone—TUBB4A—medulla oblongata—amyotrophic lateral sclerosis	0.00318	0.0227	CbGeAlD
Ixabepilone—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00317	0.00933	CcSEcCtD
Ixabepilone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00929	CcSEcCtD
Ixabepilone—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00927	CcSEcCtD
Ixabepilone—TUBB2A—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00311	0.00597	CbGpPWpGaD
Ixabepilone—TUBB2B—medulla oblongata—amyotrophic lateral sclerosis	0.00307	0.022	CbGeAlD
Ixabepilone—TUBB1—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00304	0.00584	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00894	CcSEcCtD
Ixabepilone—TUBB2B—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00303	0.00582	CbGpPWpGaD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00303	0.00582	CbGpPWpGaD
Ixabepilone—TUBB6—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00303	0.00582	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00303	0.00582	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.003	0.00577	CbGpPWpGaD
Ixabepilone—TUBB3—brain—amyotrophic lateral sclerosis	0.003	0.0214	CbGeAlD
Ixabepilone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.003	0.00883	CcSEcCtD
Ixabepilone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00877	CcSEcCtD
Ixabepilone—TUBB1—brain—amyotrophic lateral sclerosis	0.00293	0.021	CbGeAlD
Ixabepilone—TUBB3—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00293	0.00562	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00293	0.00562	CbGpPWpGaD
Ixabepilone—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00858	CcSEcCtD
Ixabepilone—TUBB—medulla oblongata—amyotrophic lateral sclerosis	0.00291	0.0208	CbGeAlD
Ixabepilone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00854	CcSEcCtD
Ixabepilone—TUBB2A—medulla oblongata—amyotrophic lateral sclerosis	0.00289	0.0207	CbGeAlD
Ixabepilone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00852	CcSEcCtD
Ixabepilone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00848	CcSEcCtD
Ixabepilone—TUBB6—medulla oblongata—amyotrophic lateral sclerosis	0.00285	0.0204	CbGeAlD
Ixabepilone—TUBB4A—spinal cord—amyotrophic lateral sclerosis	0.00284	0.0203	CbGeAlD
Ixabepilone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00835	CcSEcCtD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00283	0.00544	CbGpPWpGaD
Ixabepilone—TUBB2A—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00283	0.00544	CbGpPWpGaD
Ixabepilone—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00828	CcSEcCtD
Ixabepilone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00823	CcSEcCtD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00277	0.00532	CbGpPWpGaD
Ixabepilone—TUBB1—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00277	0.00532	CbGpPWpGaD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00276	0.00531	CbGpPWpGaD
Ixabepilone—TUBB2B—spinal cord—amyotrophic lateral sclerosis	0.00274	0.0196	CbGeAlD
Ixabepilone—TUBB4A—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00273	0.00524	CbGpPWpGaD
Ixabepilone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00791	CcSEcCtD
Ixabepilone—TUBB—spinal cord—amyotrophic lateral sclerosis	0.00259	0.0185	CbGeAlD
Ixabepilone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00258	0.0076	CcSEcCtD
Ixabepilone—TUBB2A—spinal cord—amyotrophic lateral sclerosis	0.00258	0.0184	CbGeAlD
Ixabepilone—TUBB6—spinal cord—amyotrophic lateral sclerosis	0.00254	0.0182	CbGeAlD
Ixabepilone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00738	CcSEcCtD
Ixabepilone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00737	CcSEcCtD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.0025	0.0048	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.0025	0.0048	CbGpPWpGaD
Ixabepilone—TUBB4B—Chaperonin-mediated protein folding—TUBA4A—amyotrophic lateral sclerosis	0.0025	0.00479	CbGpPWpGaD
Ixabepilone—TUBB4A—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00249	0.00478	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00249	0.00478	CbGpPWpGaD
Ixabepilone—TUBB4B—medulla oblongata—amyotrophic lateral sclerosis	0.00248	0.0177	CbGeAlD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00248	0.00475	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00723	CcSEcCtD
Ixabepilone—TUBB—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00245	0.0047	CbGpPWpGaD
Ixabepilone—Cough—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00718	CcSEcCtD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00241	0.00463	CbGpPWpGaD
Ixabepilone—TUBB4A—nervous system—amyotrophic lateral sclerosis	0.00239	0.0171	CbGeAlD
Ixabepilone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.007	CcSEcCtD
Ixabepilone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00238	0.007	CcSEcCtD
Ixabepilone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.007	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00696	CcSEcCtD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00235	0.00451	CbGpPWpGaD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00234	0.00449	CbGpPWpGaD
Ixabepilone—TUBB2B—nervous system—amyotrophic lateral sclerosis	0.00231	0.0165	CbGeAlD
Ixabepilone—TUBB4A—central nervous system—amyotrophic lateral sclerosis	0.0023	0.0164	CbGeAlD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00229	0.0044	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00228	0.00439	CbGpPWpGaD
Ixabepilone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00672	CcSEcCtD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—TUBA4A—amyotrophic lateral sclerosis	0.00228	0.00437	CbGpPWpGaD
Ixabepilone—TUBB4B—Protein folding—TUBA4A—amyotrophic lateral sclerosis	0.00228	0.00437	CbGpPWpGaD
Ixabepilone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00667	CcSEcCtD
Ixabepilone—TUBB4A—cerebellum—amyotrophic lateral sclerosis	0.00225	0.0161	CbGeAlD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00225	0.00432	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00225	0.00432	CbGpPWpGaD
Ixabepilone—Shock—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00661	CcSEcCtD
Ixabepilone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00659	CcSEcCtD
Ixabepilone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00657	CcSEcCtD
Ixabepilone—TUBB2B—central nervous system—amyotrophic lateral sclerosis	0.00222	0.0159	CbGeAlD
Ixabepilone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00652	CcSEcCtD
Ixabepilone—TUBB4B—spinal cord—amyotrophic lateral sclerosis	0.00221	0.0158	CbGeAlD
Ixabepilone—TUBB2A—nervous system—amyotrophic lateral sclerosis	0.00217	0.0155	CbGeAlD
Ixabepilone—TUBB2B—cerebellum—amyotrophic lateral sclerosis	0.00217	0.0155	CbGeAlD
Ixabepilone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0064	CcSEcCtD
Ixabepilone—TUBB6—nervous system—amyotrophic lateral sclerosis	0.00214	0.0153	CbGeAlD
Ixabepilone—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00627	CcSEcCtD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—TUBA4A—amyotrophic lateral sclerosis	0.00209	0.00402	CbGpPWpGaD
Ixabepilone—TUBB2A—central nervous system—amyotrophic lateral sclerosis	0.00209	0.015	CbGeAlD
Ixabepilone—TUBB—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00208	0.004	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00612	CcSEcCtD
Ixabepilone—TUBB6—central nervous system—amyotrophic lateral sclerosis	0.00206	0.0147	CbGeAlD
Ixabepilone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00607	CcSEcCtD
Ixabepilone—TUBB—cerebellum—amyotrophic lateral sclerosis	0.00206	0.0147	CbGeAlD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00205	0.00394	CbGpPWpGaD
Ixabepilone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00603	CcSEcCtD
Ixabepilone—TUBB2A—cerebellum—amyotrophic lateral sclerosis	0.00205	0.0146	CbGeAlD
Ixabepilone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00599	CcSEcCtD
Ixabepilone—TUBB4A—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00203	0.00389	CbGpPWpGaD
Ixabepilone—TUBB6—cerebellum—amyotrophic lateral sclerosis	0.00202	0.0144	CbGeAlD
Ixabepilone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00584	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00197	0.0058	CcSEcCtD
Ixabepilone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00579	CcSEcCtD
Ixabepilone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00574	CcSEcCtD
Ixabepilone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00574	CcSEcCtD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00195	0.00374	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00191	0.00367	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—TUBA4A—amyotrophic lateral sclerosis	0.00188	0.0036	CbGpPWpGaD
Ixabepilone—TUBB4B—nervous system—amyotrophic lateral sclerosis	0.00186	0.0133	CbGeAlD
Ixabepilone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00549	CcSEcCtD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00186	0.00358	CbGpPWpGaD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00186	0.00358	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—TUBA4A—amyotrophic lateral sclerosis	0.00185	0.00356	CbGpPWpGaD
Ixabepilone—TUBB4A—brain—amyotrophic lateral sclerosis	0.00183	0.013	CbGeAlD
Ixabepilone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00531	CcSEcCtD
Ixabepilone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00531	CcSEcCtD
Ixabepilone—TUBB4B—central nervous system—amyotrophic lateral sclerosis	0.00179	0.0128	CbGeAlD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—DCTN1—amyotrophic lateral sclerosis	0.00178	0.00342	CbGpPWpGaD
Ixabepilone—TUBB2B—brain—amyotrophic lateral sclerosis	0.00176	0.0126	CbGeAlD
Ixabepilone—TUBB4B—cerebellum—amyotrophic lateral sclerosis	0.00175	0.0125	CbGeAlD
Ixabepilone—TUBB4A—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00172	0.00331	CbGpPWpGaD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.0017	0.00327	CbGpPWpGaD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.0017	0.00327	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00169	0.00324	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00169	0.00324	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00495	CcSEcCtD
Ixabepilone—TUBB—brain—amyotrophic lateral sclerosis	0.00167	0.0119	CbGeAlD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00166	0.0032	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00166	0.0032	CbGpPWpGaD
Ixabepilone—TUBB2A—brain—amyotrophic lateral sclerosis	0.00166	0.0119	CbGeAlD
Ixabepilone—TUBB6—brain—amyotrophic lateral sclerosis	0.00164	0.0117	CbGeAlD
Ixabepilone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00482	CcSEcCtD
Ixabepilone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00475	CcSEcCtD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00158	0.00304	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—DCTN1—amyotrophic lateral sclerosis	0.00158	0.00303	CbGpPWpGaD
Ixabepilone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00459	CcSEcCtD
Ixabepilone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00444	CcSEcCtD
Ixabepilone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00427	CcSEcCtD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00145	0.00278	CbGpPWpGaD
Ixabepilone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00423	CcSEcCtD
Ixabepilone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00423	CcSEcCtD
Ixabepilone—TUBB—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00143	0.00276	CbGpPWpGaD
Ixabepilone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00421	CcSEcCtD
Ixabepilone—TUBB4B—brain—amyotrophic lateral sclerosis	0.00142	0.0102	CbGeAlD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.00141	0.00272	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.0014	0.00269	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.0014	0.00269	CbGpPWpGaD
Ixabepilone—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—GSTP1—amyotrophic lateral sclerosis	0.00139	0.00266	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00138	0.00265	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00138	0.00265	CbGpPWpGaD
Ixabepilone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00399	CcSEcCtD
Ixabepilone—TUBB4B—G2/M Transition—TUBA4A—amyotrophic lateral sclerosis	0.00128	0.00246	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—OPTN—amyotrophic lateral sclerosis	0.00128	0.00246	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—TUBA4A—amyotrophic lateral sclerosis	0.00126	0.00242	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—OPTN—amyotrophic lateral sclerosis	0.00126	0.00242	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00119	0.00228	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.00117	0.00225	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—DCTN1—amyotrophic lateral sclerosis	0.00109	0.00209	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—DCTN1—amyotrophic lateral sclerosis	0.00107	0.00206	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00101	0.00195	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00101	0.00195	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000979	0.00188	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000949	0.00182	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000928	0.00178	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000833	0.0016	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000769	0.00148	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000769	0.00148	CbGpPWpGaD
Ixabepilone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000766	0.00547	CbGeAlD
Ixabepilone—TUBB4B—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000762	0.00146	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000742	0.00143	CbGpPWpGaD
Ixabepilone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000737	0.00527	CbGeAlD
Ixabepilone—TUBB2A—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000719	0.00138	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000703	0.00135	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000703	0.00135	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000703	0.00135	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000679	0.0013	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000658	0.00126	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000643	0.00123	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000641	0.00123	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000641	0.00123	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000631	0.00121	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000626	0.0012	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000619	0.00119	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0006	0.00115	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000586	0.00113	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000582	0.00112	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000582	0.00112	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000577	0.00111	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000577	0.00111	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000563	0.00108	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000545	0.00105	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000537	0.00103	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000537	0.00103	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000533	0.00102	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000528	0.00101	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000526	0.00101	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—amyotrophic lateral sclerosis	0.000489	0.000938	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000481	0.000924	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.00048	0.000922	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.00048	0.000922	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00048	0.000921	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00048	0.000921	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000478	0.000919	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000463	0.00089	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000456	0.000877	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000449	0.000862	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000445	0.000854	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000445	0.000854	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000439	0.000842	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000437	0.00084	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000413	0.000793	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000413	0.000793	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000408	0.000784	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000407	0.000781	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000407	0.000781	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000404	0.000775	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000404	0.000775	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000399	0.000766	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000398	0.000764	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000398	0.000764	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000394	0.000756	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00039	0.000749	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000386	0.000742	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000378	0.000726	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000378	0.000725	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000378	0.000725	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000369	0.000709	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000364	0.000699	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000364	0.000699	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.00036	0.000692	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000351	0.000674	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000351	0.000674	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000351	0.000674	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000351	0.000674	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000346	0.000664	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000343	0.000659	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000343	0.000659	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000339	0.000651	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000339	0.000651	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000339	0.000651	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000338	0.000649	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000332	0.000637	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000332	0.000637	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000328	0.000631	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000328	0.000631	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000321	0.000617	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000321	0.000617	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000321	0.000617	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000314	0.000603	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000313	0.000601	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000313	0.000601	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00031	0.000596	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.000309	0.000594	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000303	0.000582	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000302	0.000581	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000293	0.000562	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000288	0.000554	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000288	0.000554	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000286	0.00055	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000282	0.000541	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000264	0.000507	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000264	0.000507	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000258	0.000495	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000257	0.000494	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000254	0.000487	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000254	0.000487	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000245	0.00047	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000237	0.000455	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000235	0.000451	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000232	0.000445	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000208	0.0004	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.00019	0.000366	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000162	0.000312	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000107	0.000206	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000107	0.000206	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000103	0.000199	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.0001	0.000192	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	9.8e-05	0.000188	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	8.8e-05	0.000169	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	8.05e-05	0.000155	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.27e-05	0.00014	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.17e-05	0.000138	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—amyotrophic lateral sclerosis	6.29e-05	0.000121	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.57e-05	0.000107	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.57e-05	0.000107	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—amyotrophic lateral sclerosis	5.21e-05	0.0001	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.09e-05	9.78e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—amyotrophic lateral sclerosis	4.77e-05	9.15e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.74e-05	9.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.45e-05	8.55e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.03e-05	7.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.05e-05	5.86e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.82e-05	5.41e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.31e-05	4.44e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.24e-05	2.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	2.19e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.4e-06	1.8e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.44e-06	1.24e-05	CbGpPWpGaD
